Shin Nippon Biomedical Laboratories LtdShin Nippon Biomedical Laboratories Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This webpage of Shin Nippon Biomedical Laboratories Ltd is assembled by All Street Sevva using leading Cognitive Robots. The SDG rating for Shin Nippon Biomedical Laboratories Ltd indicates its reporting of the United Nations Sustainable Development Goals. This webpage displays a zero-cost Environmental, Social and Governance analysis covering Shin Nippon Biomedical Laboratories Ltd.

Shin Nippon Biomedical Laboratories Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.

SDG Transparency Score for Shin Nippon Biomedical Laboratories Ltd 
Low
0 - 3
Medium
4 - 6

8.0

High Impact
7 - 10
Last Score Update: 2023-07-01
What drives the score for Shin Nippon Biomedical Laboratories Ltd 
8.0

Environmental

8.0

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
36Repligen Corp
8.1
High
36Zealand Pharma A/S
8.1
High
55Shin Nippon Biomedical Laboratories Ltd
8.0
High
55Abbott India Ltd
8.0
High
55Amrutanjan Health Care Ltd
8.0
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Shin Nippon Biomedical Laboratories Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd offer flexible work?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose water use targets?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Shin Nippon Biomedical Laboratories Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Shin Nippon Biomedical Laboratories Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Shin Nippon Biomedical Laboratories Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Shin Nippon Biomedical Laboratories Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Shin Nippon Biomedical Laboratories Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Shin Nippon Biomedical Laboratories Ltd
These potential risks are based on the size, segment and geographies of the company.

Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, provides drug discovery and development services in Japan and internationally. It offers pre-clinical laboratory services, such as good laboratory practice inspections; general and specific toxicity studies; pathological examinations; PK/PD of biopharmaceuticals, immunotoxicity tests, and antibody production; reproductive and developmental toxicity studies; pharmacology and pharmacological efficacy studies; and imaging services. The company also engages in the establishment and validation of analytical methods, analysis of biological samples, and calculation of pharmacokinetic parameters; and provides absorption, distribution, metabolism, and excretion studies using radioisotope-labeled compounds. In addition, it provides site management organization services for clinical trials; clinical contract research organization services; and translational research services, including research and development of nasal delivery systems, nucleic acid adjuvants, and regenerative medicines. The company was founded in 1957 and is headquartered in Tokyo, Japan.

Sorry!

Failed to process!